"The Cancer Research UK Cambridge Institute combines basic and clinical research with innovative technologies to address critical questions in the prevention, diagnosis and treatment of cancer. As one of the largest cancer research facilities in Europe, the CRUK CI provides an unrivalled biomedical research environment, bringing together the world-class science of the University with clinical and industrial partners at the Cambridge Biomedical Campus. The Institute is a department of the University of Cambridge, core funded by Cancer Research UK."

During the past decade, Cancer Research UK Cambridge Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research UK Cambridge Centre" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Research UK Cambridge Centre" are "Advanced Solid Tumor" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Cancer Research UK Cambridge Centre" in a lesser frequency.

Most popular intervention types in "Cancer Research UK Cambridge Centre" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1 - atezolizumab" (1 trials), "BNT112" (1 trials) and "Cemiplimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Research UK Cambridge Centre" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Research UK Cambridge Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cancer Research UK Cambridge Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Research UK Cambridge Centre, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".